MLTX Financials

Moonlake Immunotherapeutics - Financial statements & key metrics

Stock Price

$18.02

Market Cap

$1.30B

EPS

$-3.53

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-121.24M

EPS (Diluted)

$-1.89

Balance Sheet Highlights

Total Assets

$477.93M

Total Liabilities

$24.54M

Shareholders Equity

Cash & Equivalents

$180.43M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-116.59M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.6%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is MLTX revenue?

View MLTX's income statement for detailed revenue data.

Is MLTX profitable?

MLTX reported a loss of $121.24M in the most recent quarter.

What is MLTX market cap?

MLTX has a market capitalization of $1.30B, making it a small-cap stock.

Does MLTX have debt?

View MLTX's balance sheet for debt information.

What is MLTX cash flow?

Cash flow data is available in the full financial statements.